Q3 2023 Laboratory & Diagnostics Update

Q3 2023 Laboratory & Diagnostics Update

Despite the more challenging M&A environment from years prior, lab and diagnostic services transaction volume is generally keeping pace to historical levels. Competition amongst large industry competitors is driving the majority of the M&A activity. The largest players in the market continue to absorb market share via acquisition and joint-venture partnerships with hospitals and health systems. This partnership model is becoming commonplace across the lab continuum due to consistent downward pressure on reimbursement rates.  For this same reason and the fact that strategic investor competition is so fierce, private equity has continued to monitor the space from a distance. Where investor interest could expand are with businesses that have bespoke testing modalities and specialized capabilities that fill a void in the market and tap into new customer segments.

To print and download the full Laboratory & Diagnostics Update report, please click below…

[holo_button icon=”/wp-content/uploads/2023/10/Q3-23-Laboratory-Diagnostics.pdf”” color=”#003561″ target=”blank”]PRINT/DOWNLOAD[/holo_button]